Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome

Thorax

Volumn 64, Issue 2, 2009, Pages 174-178

  Nguyen, N P ^a   Borok, T L ^b   Welsh, J ^a   Vinh Hung, V ^c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Radiation Oncology Service   (United States)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CISPLATIN; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD VESSEL PROSTHESIS; BRAIN HEMORRHAGE; CAUSE OF DEATH; DEATH; ENDOPROSTHESIS; ENDOVASCULAR STENT; FIBRINOLYTIC THERAPY; FOREIGN BODY; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEART TAMPONADE; HEMODYNAMICS; HEMOPTYSIS; HUMAN; HYPERCOAGULABILITY; LUNG CANCER; LUNG EDEMA; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MORBIDITY; MORTALITY; PARANEOPLASTIC SYNDROME; PATIENT SAFETY; PHLEBITIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; RESPIRATORY FAILURE; RETROPERITONEAL HEMATOMA; REVIEW; SIDE EFFECT; STENT; STENT MIGRATION; SUPERIOR CAVA VEIN OBSTRUCTION; SUPERIOR CAVA VEIN SYNDROME; SYSTEMATIC REVIEW; THROMBOSIS; BLOOD VESSEL TRANSPLANTATION; METHODOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROSTHESIS; TREATMENT FAILURE;

BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; STENTS; SUPERIOR VENA CAVA SYNDROME; TREATMENT FAILURE;

EID: 60549095947     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2007.086017     Document Type: Review

References (39)

1. Lochridge S, Knibbbe W, Doty D. Obstruction of superior vena cava. Surgery 1979;85:14-24.
2. Gauden SJ. Superior vena cava syndrome induced by bronchogenic carcinoma: is this an oncological emergency? Australas Radiol 1993;37:363-6.
3. Reechaipichitkul W, Thongpaen S. Etiology and outcome of superior vena cava obstruction in adults. Southeast Asian Trop Med Public Health 2004;35:453-7.
4. Armstrong BA, Perez CA, Simpson JR, et al. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 1987;13:531-9.
5. Yellin A, Mandel M, Gechavi G, et al. Superior vena cava syndrome associated with lymphoma. Am J Dis Child 1992;146:1060-3.
6. Mose S, Stabik C, Eberlein K, et al. Retrospective analysis of the superior vena cava syndrome in irradiated cancer patients. Anticancer Res 2006;26:4933-6.
7. Charnsangavej C, Carrasco C, Wallace S, et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 1986;161:295-8.
8. Wilson E, Lyn E, Lynn A, et al. Radiological stenting provides effective palliation in malignant central venous obstruction. Clin Oncol 2002;14:228-32.
9. Chatziioannou A, Alexopoulos T, Mourikis D, et al. Stent therapy for malignant superior vena cava syndrome: Should be first line therapy or simple adjunctto radiotherapy. Eur J Radiol 2003;47:247-50.
10. Crowe MTI, Davies CH, Gaines PA. Percutaneous management of superior vena cava occlusions. Cardiovasc Interv Radiol 1995;18:367-72.
11. Thony F, Moro D, Witmeyer P, et al. Endovascular treatment of superior vena cava obstruction in patients with malignancies. Eur Radiol 1999;9:965-71.
12. Shah R, Sabanathan S, Lowe RA, et al. Stenting in malignant obstruction of superior vena cava. J Thorax Cardiovasc Surg 1996;112:335-40.
13. Marcy PY, Magne N, Bentolila F, et al. Superior vena cava obstruction: is stenting necessary. Support Care Cancer 2001;9:103-7.
14. Rosch J, Uchida BT, Hall LD, et al. Gianturco-Rosch expandable Z-stents in the treatment of superior vena cava syndrome. Cardiovas Interv Radiol 1992;15:319-27.
15. Elson JD, Becker GJ, Wholey MH, et al. Vena cava and central venous stenosis: management with Palmaz-balloon-expandable intraluminal stents. J Vasc Interv Radiol 1991;2:215-13.
16. Bierdrager E, Lampmann LEH, Lohle PNM, et al. Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy. Neth J Med 2005;63:20-3.
17. Yamagami T, Nakamura T, Kato T, et al. Hemodynamic changes after self expandable metallic stent therapy for superior vena cava syndrome. AJR Am J Roentgenol 2002;178:635-9.
18. Kee St, Kinoshita L, Razavi MK, et al. Superior vena cava syndrome: Treatment with catheter directed thrombolysis and endovascular stent placement. Radiology 1998;206:187-93.
19. Monaco RG, Bertoni H, Pallota G, et al. Use of self-expanding vascular endoprosthesis in superior vena cava syndrome. Eur J Cardiothorac Surg 2003;24:208-11.
20. Urruticoechea A, Mesia R, Dominguez J, et al. Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer. Lung Cancer 2004;43:209-14.
21. Greillier L, Barlesi F, Doddoli C, et al. Vascular stenting for palliation of superior vena cava obstruction in non-small cell lung cancer patients: a future standard procedure? Respiration 2004;71:178-83.
22. Stock KW, Jacob AL, Proske M, et al. Treatment of malignant obstruction of the superior vena cava with the self Expanding Wallstent. Thorax 1995;50:1151-6.
23. Dinkel HP, Mettke B, Schmid F, et al. Endovascular treatment of malignant superior vena cava syndrome: Is bilateral Wallstent placement superior to unilateral placement. J Endovasc Ther 2003;10:788-97.
24. Gross CM, Kramer J, Waigand J, et al. Stent implantation in patients with the superior vena cava syndrome. AJR Am J Roentgenol 1997;169:429-32.
25. Kim YI, Kim KS, Ko YC, et al. Endovascular stenting as a first choice for palliation of superior vena cava syndrome. J Korean Med Sci 2004;19:519-22.
26. Dyet JF, Nicholson A, Cook AM. The use of the Wallstent endovascular prosthesis in the treatment of malignant obstruction of the superior vena cava. Clin Radiol 1993;48:381-5.
27. Courtheoux P, Alkofer B, Refai MA, et al. Stent placement in superior vena cava syndrome. Ann Thorac Surg 2003;75:158-61.
28. Nicholson AA, Duncan EF, Anthony A, et al. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Int Radiol 1997;8:781-8.
29. Hennequin LM, Fade 0, Fays JG, et al. Superior vena cava stent placement: Results with the Wallstent endoprosthesis. Radiology 1995;196:353-61.
30. Tanigawa N, Sawada S, Mishima K, et al. Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors. Acta Radiol 1998;39:669-74.
31. Tan BS, Htoo MM, Yeong KY. The use of metallic stents in the treatment of malignant superior vena cava obstruction. Ann Acad Med Singapore 1995;24:198-203.
32. Furui S, Sawada S, Kuramoto K, et al. Gianturco stent placement in malignant caval obstruction: analysis of factors for predicting the outcome. Radiology 1995;195:147-52.
33. Gaines PA, Belli AM, Anderson PB, et al. Superior vena caval obstruction managed by the Gianturco Z stent. Clin Radiol 1994;49:202-8.
34. Oudkerk M, Kuijpers TJA, Schmitz PIM, et al. Self-expanding metal stents for palliative treatment of superior vena cava syndrome. Cardiovasc Int Radiol 1996;19:146-51.
35. Lanciego C, Chacon JL, Julian A, et al. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol 2001;177:585-93.
36. Lopez-Muniz JIC, Garcia GL, Lanciego PC, et al. Treatment of superior and inferior vena cava syndrome of malignant cause with Wallstent catheter placed percutaneously. Am J Clin Oncol 1997;20:293-7.
37. Nagata T, Makutani S, Uchida H, et al. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Int Radiol 2007;30:959-67.
38. Kishi K, Sonomura T, Mitsuzane K, et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 1993;189:531-5.
39. De Gregorio Ariza MA, Gamboa P, Gimeno MJ, et al. Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol 2003;13:853-62.